New drug tested to ease pain after plastic surgery
NCT ID NCT06887972
Summary
This study tested how well and how safely the drug suzetrigine worked when used as part of a multi-drug plan to manage pain after cosmetic or reconstructive surgery. It involved 100 adults who were expected to need strong pain medication for at least 3 days after their procedure. The main goal was to see how many patients rated their overall pain control as good to excellent by the end of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atlanta Center for Medical Research
Atlanta, Georgia, 30331, United States
-
Beth Israel Deaconess Medical Center - Surgery
Boston, Massachusetts, 02215, United States
-
HD Research LLC | First Surgical Hospital
Bellaire, Texas, 77401, United States
-
JBR Clinical Research
Salt Lake City, Utah, 84107, United States
-
Memorial Hermann Village
Houston, Texas, 77043, United States
Conditions
Explore the condition pages connected to this study.